Hair Loss

Dangook University Hospital Center of Hair Loss Treatment Clinical Trial

Sep 12, 2019 | Dermatology, Hair Loss

The Korean Ministry of Food and Drug Safety recently approved a Phase IIb clinical trial for Dangook University Hospital’s Dermatology Department to study the efficacy of botulinum toxin Nabota for the treatment of hair loss on 48 male study participants. Sponsored...

Over 13,200 Taxotere Lawsuits and Counting Over Permanent Hair Loss

Jul 18, 2019 | Alopecia, Hair Loss, Taxotere

Drug marker Sanofi is under fire with at least 13,200 lawsuits with more expected due to plaintiff’s permanent hair loss. Temporary hair loss was a known side effect but permanent hair loss caught patients by surprise What is Taxotere? It is a chemotherapy medication...

Lilly Korea Testing Rheumatoid Arthritis Drug For Hair Loss Treatment

Mar 7, 2019 | Hair Loss, Korea

As reported in Korea Biomedical Review, Lilly Korea is conducting a clinical trial on rheumatoid arthritis drug Olumiant (baricitinib) to test whether it will be effective for alopecia areata—spot baldness. Recently, the Korean Ministry of Food and Drug Safety...

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

159 WEST BROADWAY SUITE 200
SALT LAKE CITY, UT 84101

Dangook University Hospital Center of Hair Loss Treatment Clinical Trial

Over 13,200 Taxotere Lawsuits and Counting Over Permanent Hair Loss

Lilly Korea Testing Rheumatoid Arthritis Drug For Hair Loss Treatment

Pin It on Pinterest